Endometrial Ablation Devices Market Report 2026

Endometrial Ablation Devices Market Overview

• Endometrial Ablation Devices market size has reached to $3.87 billion in 2025 • Expected to grow to $5.55 billion in 2030 at a compound annual growth rate (CAGR) of 7.6% • Growth Driver: Expanding Endometrial Ablation Devices Market In Response To The Rising Prevalence Of Gynecological Disorders • Market Trend: Abbott Launches Innovative Volt Pulsed Field Ablation System For Advanced Afib Treatment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Endometrial Ablation Devices Market?

Endometrial ablation devices are medical devices specifically designed and used for performing endometrial ablation procedures. These devices are utilized to remove or destroy the endometrial lining of the uterus, typically to treat gynecological disorders characterized by abnormal uterine bleeding. The main types of devices in endometrial ablation devices are hysteroscopy devices, thermal balloon ablators, radiofrequency endometrial ablation devices, hydrothermal ablators, electrical ablators, and others. Hysteroscopy devices refer to medical instruments and equipment used in a diagnostic and therapeutic procedure called hysteroscopy. It includes various technologies, such as radiofrequency ablation, cryoablation, hydrothermal ablation, thermal balloon, hysteroscopic ablation, and others, that are used by end-users such as ambulatory surgery centers, clinics, and hospitals.

What Is The Endometrial Ablation Devices Market Growth Forecast?

The endometrial ablation devices market size is expected to see strong growth in the next few years. It will grow to $5.55 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing preference for outpatient gynecological procedures, rising adoption of next-generation ablation devices, expansion of single-use medical technologies, growing focus on faster recovery treatments, increasing investments in women’s health solutions. Major trends in the forecast period include increasing adoption of minimally invasive ablation procedures, rising use of radiofrequency endometrial ablation devices, growing demand for outpatient treatment options, expansion of single-use ablation technologies, enhanced focus on procedure safety and efficiency.

Global Endometrial Ablation Devices Market Segmentation

1) By Device Type: Hysteroscopy Devices, Thermal Balloon Ablators, Radiofrequency Endometrial Ablation Devices, Hydrothermal Ablators, Electrical Ablators, Other Device Types 2) By Technology: Radiofrequency Ablation, Cryoablation, Hydrothermal Ablation, Thermal Balloon, Hysteroscopic Ablation, Other Technologies 3) By End User: Ambulatory Surgery Center, Clinic, Hospital Subsegments: 1) By Hysteroscopy Devices: Hysteroscopic Resectoscopes, Operative Hysteroscopes 2) By Thermal Balloon Ablators: Single-Use Balloon Catheters, Multi-Use Balloon Systems 3) By Radiofrequency Endometrial Ablation Devices: Bipolar Rf Systems, Monopolar Rf Systems 4) By Hydrothermal Ablators: Heated Saline Infusion Systems, Water-Based Ablation Devices 5) By Electrical Ablators: Electrosurgical Systems, Electrical Current-Based Devices 6) By Other Device Types: Cryoablation Devices, Microwave Endometrial Ablation Systems, Laser Ablation Devices

What Are The Drivers Of The Endometrial Ablation Devices Market?

The prevalence of gynecological disorders is expected to propel the growth of the endometrial ablation devices market going forward. Gynecological disorders refer to medical conditions that specifically affect the female reproductive system. These disorders can include various conditions such as menstrual disorders, endometriosis, polycystic ovary syndrome (PCOS), uterine fibroids, pelvic inflammatory disease (PID), and ovarian cysts, among others. Endometrial ablation devices are procedural devices that are used to treat gynecological disorders by destroying the lining of the uterus (endometrium), which can help reduce or stop heavy menstrual bleeding and treat adenomyosis and endometrial hyperplasia. For instance, in May 2025, according to the Cancer Council Australia, an Australia-based national nonprofit organization, in 2023, 231 females in Victoria were diagnosed with invasive cervical cancer, which corresponds to a current diagnosis rate of 6.4 cases per 100,000 females. Therefore, the increase in the prevalence of gynecological disorders is driving the growth of the endometrial ablation devices industry. The growing healthcare spending is expected to propel the growth of the endometrial ablation devices market in the coming years. Healthcare expenditure refers to the entire number of financial resources provided for healthcare services, goods, and infrastructure within a certain country, area, or organization. Efficient and focused healthcare spending contributes to increased connectivity, safety, and general efficacy of endometrial ablation operations, resulting in better outcomes for women with gynecological disorders. For instance, in May 2023, according to the Office for National Statistics, a UK-based government department, UK healthcare spending totaled about $354.88 billion (£283 billion), marking a nominal increase of 0.7% from 2022. Therefore, growing healthcare spending is driving the growth of the endometrial ablation device industry.

Key Players In The Global Endometrial Ablation Devices Market

Major companies operating in the endometrial ablation devices market are Hologic Inc., Medtronic plc, Boston Scientific Corporation, Olympus Corporation, The Cooper Companies Inc., Cook Medical Incorporated, Karl Storz SE & Co. KG, Richard Wolf GmbH, B. Braun Melsungen AG, Minerva Surgical Inc., AEGEA Medical Inc., Channel Medsystems Inc., Lina Medical ApS, Biolitec AG, AngioDynamics Inc., Albyn Medical Ltd., Ecleris S.R.L., Surkon Medical Co. Ltd., Omnitech Systems Inc., Veldana Medical SA

Global Endometrial Ablation Devices Market Trends and Insights

Major companies operating in the endometrial ablation devices market are focusing on developing advanced solutions, such as a field ablation system to enhance efficacy and patient comfort. A field ablation system refers to a medical device used to treat abnormal tissue, particularly in the heart, by delivering energy (such as radiofrequency, laser, or cryotherapy) to a targeted area. For instance, in January 2024, Abbott Laboratories, a US-based medical device company, launched its Volt Pulsed Field Ablation (PFA) System, initiating the first human trials aimed at treating atrial fibrillation (AFib). This innovative technology utilizes pulsed field energy to selectively disrupt heart muscle cells, minimizing damage to surrounding tissues compared to traditional thermal ablation methods. The system features a balloon in a basket catheter design for enhanced precision and stability, and it integrates with the EnSite X cardiac mapping platform for improved procedural accuracy. Initial trials are being conducted in Australia, with plans for expansion into other markets, positioning Abbott at the forefront of advancements in AFib treatment as the demand for effective therapies continues to grow.

Regional Outlook

North America was the largest region in the endometrial ablation devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Endometrial Ablation Devices Market?

The endometrial ablation devices market consists of sales of radiofrequency ablation devices, cryoablation devices, hydrothermal devices, and microwave ablation devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.